Robbins, Paul D.

Barriers to the Preclinical Development of Therapeutics that Target Aging Mechanisms: Table 1.

Burd, C. E., Gill, M. S., Niedernhofer, L. J., Robbins, P. D., Austad, S. N., Barzilai, N., & Kirkland, J. L. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences

Genetics, Aging, and Longevity in Model OrganismsTelomeres, Telomerase, and Senescence

Cited by 28

The Ercc 1-/Δ mouse model of accelerated senescence and aging for identification and testing of novel senotherapeutic interventions

Wong, A., Kieu, T., & Robbins, P. D. (2020) · Aging

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 20

Ensemble of Time-Evolving SASP Gene Sets Identifies IGFBP7 and CDKN1A as a Potential Marker Pair for Senescent Fibroblast Subpopulations Across Tissues

Kim, H., Kummerfeld, E., Niedernhofer, L. J., Aliferis, C., Robbins, P. D., & Wang, J. (2026) · International Journal of Molecular Sciences

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 1